Adlarity
Commercial- Indications
- Alzheimer's Disease
Company intelligence / Profile preview
Corium Innovations is an established leader in transdermal and oral thin film drug delivery technologies. The company has developed proprietary platforms such as Corplex®, enabling the development and manufacture of innovative therapies for millions of patients who require alternatives to traditional oral or injectable medications. Their technologies have supported both branded and complex generic products through all stages from formulation to commercial launch. As a service provider rather than a product innovator, clinical results pertain to their clients’ programs.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Corium Innovations.